Tickerplace logo

Tickerplace

NovoCure Limited logo

NVCRNovoCure Limited

NVCR Stock Price, Valuation & Chart | NovoCure Limited

Compare
$14.070-0.34 (-2.36%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Instruments & Supplies
OverviewFinancialsDividendsRatios

NVCR Historical price chart

NVCR Key Stats

Market Capitalization1.64B
PE Ratio-10.82
EPS-1.3
Trading Volume1.29M
Today's High/Low14.36/13.87
Dividend Yield0.00
52 Week High/Low21.45/9.82
Shares Outstanding116.45M
NVCR Financial Statement
NVCR Analyst ratings
NVCR Analysis & performance metrics

NVCR Company profile

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid…

NVCR Management team

Management
Ashley CordovaCEO
Chief Executive Officer & Director
Frank Leonard
Executive Vice President & President of Novocure Oncology
Michael Puri
Chief Human Resources Officer
Nicolas Leupin M.B.A., M.D., Ph.D.
Chief Medical Officer
Uri Weinberg M.D., Ph.D.
Chief Innovation Officer
Mukund ParavasthuCOO
Chief Operating Officer
Christoph BrackmannCFO
Chief Financial Officer
Barak Ben-Arye
General Counsel
Total 8 executives

NVCR Frequently asked questions

What is NovoCure Limited (NVCR) Stock Price?

Current stock price of NovoCure Limited (NVCR) stock is $14.070. The stock price is -2.36% lower in the session. The intraday range can be seen from this page. Volume of NovoCure Limited (NVCR) stock is 1.29M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the NovoCure Limited (NVCR) stock price going up or down today?

The stock price of NovoCure Limited (NVCR) can change with earnings, company news, and overall market sentiment. NovoCure Limited operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NovoCure Limited stock expensive at its current price?

Whether NovoCure Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NVCR on this page is -10.82. EPS on this page is -1.30. Compare those figures with peers and growth expectations before deciding if the current NovoCure Limited price is justified.

How has the stock price of NovoCure Limited (NVCR) performed historically?

Historical performance for NovoCure Limited (NVCR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NVCR reacted to past earnings and market events.

Should I buy NovoCure Limited (NVCR) stock, at this price?

Buying NovoCure Limited (NVCR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.